InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,070.55
(
0.00%
)
US TECH 100
17,102.40
(
0.59%
)
Dow Jones
38,503.69
(
0.00%
)
Brent Oil
87.29
(
-0.32%
)
Bitcoin
66,074.93
(
-0.51%
)
Post# of 255
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

georgejjl

Send PM Follow Ignore
Followers 137
Posts 22805
Boards Moderated 0
Alias Born 04/08/2004

georgejjl

Re: None

Thursday, 10/21/2021 7:50:26 AM

Thursday, October 21, 2021 7:50:26 AM

Post# of 255
Sio Gene Therapies Announces Positive Interim Safety and Biomarker Data from Ongoing Phase 1/2 Clinical Study of AXO-AAV-GM1 Gene Therapy in GM1 Gangliosidosis

https://investors.siogtx.com/news-releases/news-release-details/sio-gene-therapies-announces-positive-interim-safety-and

Good luck and GOD bless,
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up